Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
Biofourmis received early financing of $71.9K on 2015-12-01.
| Series | Round size | Date |
|---|---|---|
| Angel | $72K | 12/2015 |
| Angel | $1M | 08/2016 |
| Seed | $500K | 05/2017 |
| Series A | $5M | 12/2017 |
| Series A | $2M | 05/2018 |
| Series B | $35M | 05/2019 |
| Series C | $100M | 09/2020 |
| Investors | Security type |
|---|---|
| EDEN STRATEGY INSTITUTE LLP | Angel |
| EDEN STRATEGY INSTITUTE LLP | Angel |
| SPESNET PTE. LTD. | Angel |
| SPESNET PTE. LTD. | Seed |
| Openspace Ventures | Series A |
| Aviva Ventures | Series A |
| Aviva Ventures | Series A |
| SGInnovate | Series A |
| Openspace Ventures | Series B |
| Sequoia Capital India | Series B |
| EDBI PTE LTD | Series B |
| Aviva Ventures | Series B |
| MassMutual Ventures Southeast Asia (MMV SEA) | Series B |
| SGInnovate | Series B |
| Jianke | Series B |
| Openspace Ventures | Series C |
| SoftBank Investment Advisers | Series C |
| EDBI PTE LTD | Series C |
| Capikris Foundation | Series C |
| MassMutual Ventures Southeast Asia (MMV SEA) | Series C |
| Sequoia Capital | Series C |
Biofourmis's top competitor, Pear Therapeutics, earned an annual revenue of $20.0M.
Biofourmis's smallest competitor is SpIntellx with revenue of $87.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Bloomlife | - | $7.0M | 28 | - |
| Pear Therapeutics | - | $20.0M | 180 | - |
| SpIntellx | - | $87,000 | 6 | - |
| CAMP4 Therapeutics | - | $890,000 | 46 | - |
| Rimidi | - | $1.0M | 22 | - |
| OneThree Biotech | - | $130,000 | 7 | - |
Zippia gives an in-depth look into the details of Biofourmis, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Biofourmis. The employee data is based on information from people who have self-reported their past or current employments at Biofourmis. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Biofourmis. The data presented on this page does not represent the view of Biofourmis and its employees or that of Zippia.
Biofourmis may also be known as or be related to Biofourmis, Biofourmis Inc and Biofourmis Inc.